Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rubrik Inc. Class A Common Stock (RBRK) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Rubrik Inc. Class A Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Rubrik Inc. Class A Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Rubrik Inc. Class A Common Stock trades at $111 (market cap $24.56B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Rubrik Inc. Class A Common Stock is far larger — about 2.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Rubrik Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rubrik Inc. Class A Common Stock for 4 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

RBRKRDY
Market Cap
$24.56B$10.78B
Volume
2,289,4652,724,343
Sector
TechnologyHealth
52-Week High
$125.80$15.38
52-Week Low
$43.81$11.38
Typical Hold Time
4 Days0 Days
Enterprise Value
$23.96B$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rubrik Inc. Class A Common Stock

Rubrik (RBRK) trades at $118.47, down 1.28% on the day, with strong technical momentum showing bullish moving averages and support at $118. The company demonstrates impressive revenue growth, with 2026 revenue reaching $1.5B and recent earnings beats, though profitability remains negative with a -16.5% net margin. Recent news highlights expansion of AI security offerings including Rubrik Code Guardian and strong institutional buying interest.

Rubrik presents a compelling growth story in cybersecurity with 100% analyst buy ratings and $105.08 consensus target, though current price exceeds this. Key risks include persistent losses despite revenue growth and competitive AI security landscape. The stock's technical strength and AI-driven demand create upside potential, but profitability concerns warrant careful monitoring of margin improvement.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RBRK

No sentiment data available yet.

RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Rubrik Inc. Class A Common Stock

Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.

Read more on RBRK →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →